Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1850 of 6351
-
New study tests if draining the gallbladder early prevents repeat attacks in frail patients
Disease control Recruiting nowObjectives Acute cholecystitis commonly occurs in elderly patients who are at high-risk for surgery. Whether upfront Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is advantageous over antibiotics first for mild acute cholecystitis is uncertain. Hypothesis to be tes…
Phase 3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a One-Time immune cell infusion help older leukemia patients avoid harsh chemo?
Disease control OngoingThis phase I trial tests the safety, side effects, and best dose of autologous anti-CD19 CAR-expressing T lymphocytes (CD19-CAR T cells) in older adults with B-cell acute lymphoblastic leukemia. Chimeric antigen receptor (CAR) T-cell therapy is a type of treatment in which a pati…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill shows promise for tough blood cancers
Disease control Recruiting nowThe goal of this phase 1/2 multicenter, open-label, single-arm dose escalation and expansion study is to assess the safety, tolerability, pharmacokinetic and pharmacodynamic profile of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) and higher risk…
Phase 1/2 • Sponsor: Chordia Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New heart failure drug tested in 2,400 chinese patients
Disease control CompletedThis is an observational study in which data from people in China with chronic heart failure with reduced ejection fraction (HFrEF) who will be receiving vericiguat treatment are collected. Vericiguat treatment will be compared to available data on standard of care (SOC) treatmen…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Walking buddy program aims to boost survival in prostate cancer patients
Disease control Recruiting nowDespite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active. Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reducti…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Brain scans could predict MS disability years before symptoms worsen
Knowledge-focused Recruiting nowThe transition from relapsing-remitting multiple sclerosis to secondarily progressive multiple sclerosis (SPMS) is difficult to identify. Typically, SPMS is diagnosed retrospectively, with a significant delay, on the basis of a clinical history of progressive worsening, independe…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New stent design tested in thousands with complex heart blockages
Disease control OngoingThe NAGOMI COMPLEX PMCF (Post-Market Clinical Follow-up) study has been designed to expand the knowledge about outcomes with the Ultimaster Nagomi™ sirolimus eluting coronary stent system (Ultimaster Nagomi™) in complex PCI subjects. The features for a complex PCI are based upon …
Sponsor: Terumo Europe N.V. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
A brain health bootcamp for seniors: could group classes ward off dementia?
Prevention CompletedThis is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Progr…
Sponsor: Posit Science Corporation • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
Shocking nerve pain away: new device trial for diabetic neuropathy
Symptom relief OngoingThe purpose of this post-market study is to evaluate changes in pain and neurological function with high frequency, 10 kHz spinal cord stimulation (SCS) therapy in patients with chronic, intractable lower limb pain associated with diabetic peripheral neuropathy, a condition known…
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Poo pills could be the key to a healthier old age
Disease control Recruiting nowA severe public health issue facing global population is aging. Increasing preclinical and clinical data indicate the contribution of gut microbiome on aging and aging-related diseases such as cardiovascular disease, Alzheimer Disease, and diabetes. Interventions on microbiota ar…
Early phase 1 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New PNH pill matches standard infusion therapy in trial
Disease control CompletedThe purpose of the study was to find out if iptacopan is effective and safe in adult patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who switched from their current standard of care treatment (eculizumab or ravulizumab) to study treatment, iptacopan/LNP023.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Parents' online training may cut HIV risk for gay teens
Prevention OngoingGay and bisexual youth make up 80% of all new HIV infections among adolescents ages 14-19 in the United States, yet interventions to improve sexual health outcomes in these youth are extremely limited. Our team has developed an intervention -- Parents and Adolescents Talking abou…
Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Gene test could personalize stroke prevention
Disease control OngoingA fifth of ischemic stroke or transient ischemic attack (TIA) patients will have recurrent events within the first 3 months \[Refs 1-3\] despite aggressive medical therapy with antiplatelets and risk factor control. Clopidogrel is one of the mainstays of antiplatelet secondary p…
Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug shows promise for heart failure patients with lung pressure problems
Disease control CompletedThis study is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart failure (HF) and pulmonary hypertension (PH) Group 2
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could gentle electrical pulses ease stroke After-Effects?
Symptom relief Recruiting nowTo evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality …
Sponsor: University of Las Palmas de Gran Canaria • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can a simple Self-Affirmation exercise boost COVID testing?
Prevention CompletedThe ongoing Oregon Saludable: Juntos Podemos (OSJP, Healthy Oregon: Together We Can) project was developed to directly address the COVID-19 related health disparities among Latinx communities through community engagement funded by Phase I and II of the RADx-UP initiative. This pr…
Sponsor: University of Oregon • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Could a TB drug make brain zaps work better for depression?
Symptom relief OngoingThe goal of this clinical trial is to investigate if the drug D-Cycloserine (DCS) improves the antidepressant effects of Intermittent Theta Burst Stimulation (iTBS), a non-invasive brain stimulation therapy, in patients with Major Depressive Disorder (MDD). The main questions it …
Phase 2 • Sponsor: The Alfred • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can exercise and brain training fix memory after a head injury?
Symptom relief Recruiting nowNew learning and memory impairment (NLMI) is a common and devastating manifestation of TBI associated with substantial life burdens. Persons with moderate to severe TBI have shown improvement in NLM for prose material (e.g. story) as well as beneficial changes in default-mode net…
Phase 1 • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 14:01 UTC
-
New combo therapy aims to boost liver cancer surgery success
Disease control OngoingThe goal of this research study is to evaluate the safety and tolerability of tremelimumab and durvalumab with or without Selective Internal Yttrium-90 Radioembolization (SIRT) in participants with resectable hepatocellular carcinoma (HCC) who will undergo liver surgery. The nam…
Phase 1 • Sponsor: Jiping Wang, MD, PhD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a Parkinson's drug help restore pleasure in depression?
Symptom relief CompletedThe purpose of the study is to assess the long-term efficacy and safety of add-on pramipexole for treatment of patients with anhedonic depression.
Phase 3 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC